| Stage | INVX | % of rev | BKR | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $245M | 100.00% | $8.0B | 100.00% | BKR ×32.77 |
| Gross profit | $84M | 34.16% | $1.9B | 24.02% | INVX +10.1pp |
| Operating income | $34M | 13.79% | $853M | 10.63% | INVX +3.2pp |
| Pre-tax income | $35M | 14.46% | $519M | 6.47% | INVX +8.0pp |
| Net income | $25M | 10.22% | $422M | 5.26% | INVX +5.0pp |
| Stage | INVX | BKR | Gap · A − B |
|---|---|---|---|
| Revenue | $245M100.00% | $8.0B100.00% | BKR ×32.77 |
| Gross profit | 34.16%$84M | 24.02%$1.9B | INVX +10.1pp |
| Operating income | 13.79%$34M | 10.63%$853M | INVX +3.2pp |
| Pre-tax income | 14.46%$35M | 6.47%$519M | INVX +8.0pp |
| Net income |
| 10.22%$25M |
| 5.26%$422M |
| INVX +5.0pp |
No shared counterparties.